Since antibodies against AT1-R and ETA-R have been linked to the pathogenesis of SSc [11], we analyzed whether signalling through AT1-R and ETA-R mediated the effect of SSc-IgG on IL-6 release. Here, IL6 is linked to systemic sclerosis.